Get started
Author

Emery G. Dora

Observed names: E. G. Dora, Emery Dora, Emery G Dora
ORCID: 0000-0002-0587-2751
Observed ORCID: 0000-0002-0587-2751
OpenAlex ID: A5072741174
Modeling human adaptive immune responses with tonsil organoids
2021 · Lisa E. Wagar, Ameen Salahudeen, et al. · Nature Medicine · 350
PDF
Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model
2022 · Stephanie N. Langel, Susan Johnson, et al. · Science Translational Medicine · 125
Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model
2021 · Susan Johnson, Clarissa I Martinez, et al. · The Journal of Infectious Diseases · 34
Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection
2020 · Anne C. Moore, Emery G. Dora, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 22
PDF
An adjuvanted adenovirus 5-based vaccine elicits neutralizing antibodies and protects mice against chikungunya virus-induced footpad swelling
2019 · Emery G. Dora, Shannan L. Rossi, et al. · Vaccine · 19
SARS-CoV-2 oral tablet vaccination induces neutralizing mucosal IgA in a phase 1 open label trial
2022 · Susan Johnson, Clarissa I Martinez, et al. · medRxiv · 17
PDF
Hybrid Yeast–Bacteria Cloning System Used to Capture and Modify Adenoviral and Nonviral Genomes
2003 · Craig A. Hokanson, Emery Dora, et al. · Human Gene Therapy · 14
RPD3 (REC3) mutations affect mitotic recombination in Saccharomyces cerevisiae
1999 · E. G. Dora, N. Rudin, et al. · Current Genetics · 13
PDF
Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2
2023 · Molly R. Braun, Clarissa I. Martinez, et al. · Frontiers in Immunology · 9
589. Oral Tablet Vaccination Induces Heightened Cross-Reactive CD8 T Cell Responses to SARS-COV-2 in Humans
2021 · Susan Johnson, Clarissa Martinez, et al. · Open Forum Infectious Diseases · 6
PDF
Mucosal Immunization of Cynomolgus Macaques with Adenoviral Vector Vaccine Elicits Neutralizing Nasal and Serum Antibody to Several SARS-CoV-2 Variants
2022 · Becca A. Flitter, Colin A. Lester, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5
PDF
Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine Study
2024 · Molly R. Braun, Jonathan D. Lindbloom, et al. · Vaccines · 2
PDF
A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman Primates
2024 · Sarah N. Tedjakusuma, Colin A. Lester, et al. · Vaccines · 2
PDF
Adenoviral-Based Vaccine Elicits Robust Systemic and Mucosal Cross-Reactive Responses in African Green Monkeys and Reduces Shedding after SARS-CoV-2 Challenge
2022 · Sarah N. Tedjakusuma, Colin A. Lester, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
1960. Mucosal rAd5 Immunization against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in African Green Monkeys
2022 · Becca A Flitter, Sarah N Tedjakusuma, et al. · Open Forum Infectious Diseases
PDF
Works count: 15
Citation count: 619
H-index: 9
I10-index: 8
Year
Topic
Type